Preparando el escenario para dejar de fumar en el paciente con Trastorno Bipolar: intervención breve en la práctica clínica

Autores/as

  • Fernando Sarramea Reina Sofia University Hospital. CIBERSAM.
  • Maria José Jaen-Moreno Psychiatry section, Faculty of Medicine and Nursing, University of Cordoba, Cordoba, Spain http://orcid.org/0000-0003-0905-901X
  • Vicent Balanzá-Martínez University of Valencia, CIBERSAM. La Fe University and Polytechnic Hospital.
  • Maria Isabel Osuna Virgen de la Victoria University Hospital
  • José Ángel Alcalá Reina Sofia University Hospital
  • Francisco Javier Montiel Complejo Hospitalario de Jaen
  • Cristina Gómez Complejo Hospitalario de Jaen
  • María Dolores Sánchez Complejo Hospitalario de Jaen
  • Ana Belén Rico Reina Sofia University Hospital
  • Justa Redondo-Écija Instituto Provincial Bienestar Social, Diputacion de Cordoba
  • Susana Gil Reina Sofia University Hospital
  • Francisca Valdivia Reina Sofia University Hospital
  • Javier Caballero-Villarraso Reina Sofia University Hospital. Maimonides Biomedical Research Institute of Cordoba (IMIBIC).
  • Luis Gutiérrez-Rojas University of Granada

DOI:

https://doi.org/10.20882/adicciones.1006

Palabras clave:

Trastorno bipolar, Tabaco, Abandono tabaquismo, Intervención breve, Disposición para el cambio

Resumen

El consumo de tabaco es el principal factor prevenible de mortalidad en pacientes con trastorno bipolar (TB), y las posibles soluciones se encuentran bloqueadas por prejuicios acerca del deseo, posibilidades y riesgos al dejar el consumo de tabaco en estos pacientes. En 8 Centros de Salud Mental se reclutaron consecutivamente pacientes con TB. Los fumadores fueron evaluados antes y después de una intervención breve basada en las 3 As y clasificados según los “estadios de cambio” (EC) y su “disposición para el cambio” (DC). Mediante una regresión lineal múltiple se analizó la evolución del DC y su efecto sobre otras variables independientes (tratamiento farmacológico, historias de síntomas psicóticos, presencia de síntomas de ansiedad, deseo de abandono, capacidad auto-percibida y la percepción subjetiva de funcionamiento cognitivo). Se incluyeron 212 pacientes con TB estabilizados, los fumadores activos (n=101; 47.6%) pasaron a la fase de intervención, y un 80.2% la completaron. Basalmente, 75.2% consideraban la idea de dejar de fumar, después de la intervención breve, el 30.9% de los pacientes progresó en su EC. Se observó un incremento significativo del nivel de DC (53.3 vs 59.3, P=0.019). La autopercepción del rendimiento cognitivo (β=-0.35;P=0.002), el deseo de abandono (β=0.32;P=0.008), la autopercepción de la capacidad para dejar de fumar (β=-0.30;P=0.012), la edad del paciente (β=-0.72;P=0.004), la edad de inicio del tabaquismo (β=0.48;P=0.022) y los años fumando (β=0.48;P=0.025) fueron los factores que influyeron significativamente en la posibilidad de cambio tras la intervención breve. Los fumadores con TB consideran la idea de dejar de fumar y una intervención breve desarrollada en el marco de la atención a la salud mental diaria, mejoraría el nivel de preparación. La disfunción neurocognitiva asociada con el TB podría limitar la disposición de los pacientes a dejar de fumar.

Biografía del autor/a

Fernando Sarramea, Reina Sofia University Hospital. CIBERSAM.

Clinical Unit of Mental Health. Reina Sofia University Hospital, Cordoba, Spain.Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, 33006 Oviedo, Spain

Maria José Jaen-Moreno, Psychiatry section, Faculty of Medicine and Nursing, University of Cordoba, Cordoba, Spain

Psychiatry section, Faculty of Medicine and Nursing, University of Cordoba, Cordoba, Spain

Vicent Balanzá-Martínez, University of Valencia, CIBERSAM. La Fe University and Polytechnic Hospital.

Teaching Unit of Psychiatry and Psychological Medicine, Department of Medicine, University of Valencia, CIBERSAM, Valencia, Spain.Service of Psychiatry, La Fe University and Polytechnic Hospital, Valencia, Spain.

Maria Isabel Osuna, Virgen de la Victoria University Hospital

Clinical Unit of Mental Health. Virgen de la Victoria University Hospital, Malaga, Spain

José Ángel Alcalá, Reina Sofia University Hospital

Clinical Unit of Mental Health. Reina Sofia University Hospital, Cordoba, Spain

Francisco Javier Montiel, Complejo Hospitalario de Jaen

Clinical Unit of Mental Health. Complejo Hospitalario de Jaen, Jaen, Spain

Cristina Gómez, Complejo Hospitalario de Jaen

Clinical Unit of Mental Health. Complejo Hospitalario de Jaen, Jaen, Spain

María Dolores Sánchez, Complejo Hospitalario de Jaen

Clinical Unit of Mental Health. Complejo Hospitalario de Jaen, Jaen, Spain

Ana Belén Rico, Reina Sofia University Hospital

Clinical Unit of Mental Health. Reina Sofia University Hospital, Cordoba, Spain

Justa Redondo-Écija, Instituto Provincial Bienestar Social, Diputacion de Cordoba

Drugs and Addictions Unit. Instituto Provincial Bienestar Social, Diputacion de Cordoba, Cordoba, Spain

Susana Gil, Reina Sofia University Hospital

Clinical Unit of Mental Health. Reina Sofia University Hospital, Cordoba, Spain

Francisca Valdivia, Reina Sofia University Hospital

Clinical Unit of Mental Health. Reina Sofia University Hospital, Cordoba, Spain

Javier Caballero-Villarraso, Reina Sofia University Hospital. Maimonides Biomedical Research Institute of Cordoba (IMIBIC).

Clinical Analyses Service, Reina Sofia University Hospital, Cordoba, Spain. Maimonides Biomedical Research Institute of Cordoba (IMIBIC).

Luis Gutiérrez-Rojas, University of Granada

Psychiatry and Neurosciences Research Group (CTS-549), Institute of Neurosciences, University of Granada, Granada, Spain

Citas

Aharonovich, E., Brooks, A. C., Nunes, E .V. y Hasin, D. S. (2008). Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome. Drug and Alcohol Dependence, 95, 279-283. doi:10.1016/j.drugalcdep.2008.01.009.

Al-Halabí, S., Fernández-Artamendi, S., Díaz-Mesa, E.M., García-Álvarez, L., Flórez, G., Martínez-Santamaría, E.,… Bobes J. (2016). Tobacco and cognitive performance in schizophrenia patients: the design of the COGNICO study. Adicciones, 29, 6-12. doi:10.20882/adicciones.724.

Almadana Pacheco, V., Gómez-Bastero Fernández, A.P., Valido Morales, A., Luque Crespo, E., Monserrat, S. y Montemayor Rubio, T. (2017). Anxiety, depression and tobacco abstinence. Adicciones, 29, 233-244. doi:10.20882/adicciones.761.

Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D.,… Evins, A.E. (2016). Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet, 387, 2507-2520. doi:10.1016/S0140-6736(16)30272-0.

Ashare, R.L., Falcone, M. y Lerman, C. (2014). Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology, 76 Pt B, 581-591. doi:10.1016/j.neuropharm.2013.04.034.

Balanzá-Martínez, V., Crespo-Facorro, B., González-Pinto, A. y Vieta, E. (2015). Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates. Frontiers in Physiology, 6, 108. doi:10.3389/fphys.2015.00108.

Baune, B.T. y Malhi, G.S. (2015). A review on the impact of cognitive dysfunction on social, occupational, and general functional outcomes in bipolar disorder. Bipolar Disorders, 17 (Suppl 2), 41-55. doi:10.1111/bdi.12341.

Biener, L. y Abrams, D.B. (1991). The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychology, 10, 360-365.

Borland, R., Yong, H.H., Balmford, J., Cooper, J., Cummings, K.M., O’Connor, R.J.,… Fong, G.T. (2010). Motivational factors predict quit attempts but not maintenance of smoking cessation: findings from the International Tobacco Control Four country project. Nicotine and Tobacco Research, 12 Suppl, S4-11. doi:10.1093/ntr/ntq050.

Callaghan, R.C., Veldhuizen, S., Jeysingh, T., Orlan, C., Graham, C., Kakouris, G.,… Gatley, J. (2014). Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. Journal of Psychiatry Research, 48, 102-110. doi:10.1016/j.jpsychires.2013.09.014.

Cazard, F. y Ferreri, F. (2013). Bipolar disorders and comorbid anxiety: prognostic impact and therapeutic challenges. Encephale 39, 66-74. doi:10.1016/j.encep.2012.04.005.

Ceccarini, M., Borrello, M., Pietrabissa, G., Manzoni, G.M. y Castelnuovo, G. Assessing motivation and readiness to change for weight management and control: an in-depth evaluation of three sets of instruments. Frontiers in Psychology, 6, 511. doi:10.3389/fpsyg.2015.00511.

Chengappa, K.N., Perkins, K.A., Brar, J.S., Schlicht, P.J., Turkin, S.R,… George, T.P. (2014). Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study. Journal Clinical of Psychiatry, 75, 765-772. doi:10.4088/JCP.13m08756.

Chou, K., Chen, H.K., Hung, C.H., Chen, T.T., Chen, C.M. y Wu, B.J. (2015). Readiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 265, 249-257. doi:10.1007/s00406-014-0515-7.

CIE-10., 1992. Trastornos mentales y del comportamiento, descripciones clínicas y pautas para el diagnóstico. Madrid: Meditor.

de Leon, J., Diaz, F.J., Aguilar, M.C., Jurado, D. y Gurpegui, M. (2006). Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis. Schizophrenia Research, 86, 256-268. doi:10.1016/j.schres.2006.05.009.

Diaz, F.J., James, D., Botts, S., Maw, L., Susce, M.T. y de Leon, J. (2009). Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. Bipolar Disorders, 11, 154-165. doi:10.1111/j.1399-5618.2009.00664.x.

DiClemente, C.C., Prochaska, J.O., Fairhurst, S.K., Velicer, W.F., Velasquez M.M. y Rossi, J.S. (1991). The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. Journal of Consulting and Clinical Psychology, 59, 295–304.

DiClemente, C.C. y Prochascka, J.O. (1998). Toward a comprehensive, transtheoretical model of change: stages of change and addictive behavior. In: Miller WR, Heather N, eds. Treating Addictive Behaviors. 2nd ed. New York, Plenum. Pp: 3-24.

DiClemente, C.C., Schlundt, D. y Gemmell, L. (2004). Readiness and stages of change in addiction treatment. American Journal on Addictions, 13, 103-119. doi:10.1080/10550490490435777.

DiClemente, C.C., Delahanty, J.C., Kofeldt, M.G., Dixon, L., Goldberg, R. y Lucksted, A. (2011). Stage movement following a 5A’s intervention in tobacco dependent individuals with serious mental illness (SMI). Addictive Behaviour, 36, 261-264. doi:10.1016/j.addbeh.2010.11.002.

Etter, M. y Etter, J.F. (2004). Alcohol consumption and the CAGE test in outpatients with schizophrenia or schizoaffective disorder and in the general population. Schizophrenia Bulletin, 30, 947-956.

Evins, A.E., Cather, C. y Laffer, A. (2015). Treatment of tobacco use disorders in smokers with serious mental illness; toward clinical best practices. Harvard Review of Psychiatry, 23, 90-98. doi:10.1097/HRP.0000000000000063.

Fagerström, K.O. (1978). Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviour, 3, 235-241.

Fiore, M. y Panel, G. (2008). Treating tobacco use and dependence: 2008 update. Rockville MD: Department of Health and Human Services.

García-Portilla, M.P., Saiz, P.A., Benabarre, A., Florez, G., Bascaran, M.T., Díaz, E.M.,… Bobes, J. (2010). Impact of substance use on the physical health of patients with bipolar disorder. Acta Psychiatrica Scandinavica, 121, 437-445. doi:10.1111/j.1600-0447.2009.01498.x.

García-Portilla, M.P., García–Álvarez, L., Sarramea, F., Galvan, G., Díaz-Mesa, E., Bobes-Bascaran, T.,… Bobes, J. (2016). It is feasible and effective to help patients with severe mental disorders to quit smoking: an ecological pragmatic clinical trial with transdermal nicotine partches and varenicline. Schizophrenia Research, 176, 272-280. doi:10.1016/j.schres.2016.05.011.

George, T.P., Wu, B.S. y Weinberger, A.H. (2012). A review of smoking cessation in bipolar disorder: implications for future research. Journal of Dual Diagnosis, 8, 126–130. doi:10.1080/15504263.2012.671717.

Goes, F.S. (2015). The importance of anxiety states in bipolar disorder. Current Psychiatry Reports, 17, 3. doi:10.1007/s11920-014-0540-2.

Gómez-Peña, M., Penelo, E., Granero, R., Fernández-Aranda, F., Alvarez-Moya, E., Santamaría, J.J.,… Jiménez-Murcia, S. (2011). Motivation to change and pathological gambling: analysis of the relationship with clinical and psychopathological variables. British Journal of Clinical Psychology, 50, 196-210. doi:10.1348/014466510X511006.

Gonzalez-Pinto, A., Gutierrez, M., Ezcurra, J., Aizpuru, F., Mosquera, F., López, P. y de Leon, J. (1998). Tobacco smoking and bipolar disorder. Journal of Clinical Psychiatry, 59, 225-228.

Gutiérrez-Rojas, L., Gurpegui, M., Ayuso-Mateos, J.L., Gutiérrez-Ariza, J.A., Ruiz-Veguilla, M. y Jurado, D. (2008). Quality of life in bipolar disorder patients: a comparison with a general population sample. Bipolar Disorders, 10, 625-634. doi:10.1111/j.1399-5618.2008.00604.x.

Gwaltney, C.J., Metrik, J., Kahler, C.W. y Shiffman, S. (2009). Self-efficacy and smoking cessation: a meta-analysis. Psychol. Addictive Behaviour, 23, 56-66. doi:10.1037/a0013529.

Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.

Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.

Heatherton, T.F., Kozlowski, L.T., Frecjer, R.C. y Fageström, K.O. (1991). The Fageström Test for Nicotine Dependence: A revision of the Fageström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127. 

Heffner, J.L., Strawn, J.R., DelBello, M.P., Strakowski, S.M. y Anthenelli, R.M. (2011). The co-ocurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations. Bipolar Disorders, 13, 439-453. doi:10.1111/j.1399-5618.2011.00943.x.

Jackson, J.G., Diaz, F.J., Lopez, L. y de Leon, J. (2015). A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults. Bipolar Disorders, 17, 575-597. doi:10.1111/bdi.12319.

Japuntich, S.J., Leventhal, A.M., Piper, M.E., Bolt, D.M., Roberts, L.J., Fiore, M.C. y Baker, T.B. (2011). Smoker characteristics and smoking-cessation milestones. American Journal of Preventive Medicine, 40, 286-294. doi:10.1016/j.amepre.2010.11.016.

Kruger, J., O’Halloran, A., Rosenthal, A.C., Babb, S.D. y Fiore, M.C. (2016). Receipt of evidence-based brief cessation interventions by health professionals and use of cessation assisted treatments among current adult cigarette-only smokers: National Adult Tobacco Survey, 2009-2010. BMC Public Health, 16, 141. doi:10.1186/s12889-016-2798-2.

Marín Romero, B., Gil Roales-Nieto, J. y Moreno San Pedro, E. (2017). Self-quitting in a Spanish sample. An exploratory study. Adicciones, 29, 210-212. doi:10.20882/adicciones.925.

Miller, W.R. (2011). Motivational factors in addictive behaviors. In: Miller WR and Carroll KM, (Eds). Rethinking substance abuse: What the science shows and what we should do about it. New York: Guilford Press, pp. 134-152.

Miskowiak, K.W., Petersen, J.Z., Ott, C.V., Knorr, U., Kessing, L.V., Gallagher, P. y Robinson, L. (2016). Predictors of the discrepancy between objective and subjective cognition in bipolar disorder: a novel methodology. Acta Psychiatrica Scandinavica, 134, 511-521.

Moss, T.G., Sacco, K.A., Allen, T.M., Weinberger, A.H., Vessicchio, J.C. y George, T.P. (2009). Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug and Alcohol Dependence, 104, 94-99. doi:10.1111/acps.12649.

Prochaska, J.O. y DiClemente, C.C. (1983). Stages and processes of self-change of smoking: toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51, 390-395.

Prochaska, J.J., Reyes, R.S., Schroeder, S.A., Daniels, A.S., Doederlein, A. y Bergeson, B. (2011). An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder. Bipolar Disorders, 13, 466–473. doi:10.1111/j.1399-5618.2011.00944.x.

Rhodes, J.D. y Hawk, L.W. JR. (2016). Smoke and mirrors: The overnight abstinence paradigm as an index of disrupted cognitive function. Psychopharmacology, (Berl). 233, 1395-1404. doi:10.1007/s00213-016-4227-8.

Rice, V.H. y Stead, L.F. (2008). Nursing interventions for smoking cessation. Cochrane Database Systematic Review, CD001188. doi:10.1002/14651858.CD001188.pub3.

Rosa, A.R., Mercadé, C., Sánchez-Moreno, J., Solé, B., Mar Bonnin, C.D., Torrent, C.,… Martinez-Aran, A. (2013). Validity and reliability of a rating scale on subjective cognitive deficits in bipolar disorder (COBRA). Journal of Affective Disorders, 150, 29-36. doi:10.1016/j.jad.2013.02.022.

Rüther, T., Bobes, J., De Hert, M., Svensson, T.H., Mann, K., Batra, A.,… Möller, H.J. (2014). EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. European Psychiatry, 29, 65-82. doi:10.1016/j.eurpsy.2013.11.002.

Schroeder, S.A. (2014). Even more illness caused by smoking than previously estimated. JAMA Internal Medicine, 174, 1928-1929. doi:10.1001/jamainternmed.2014.4297.

Sharma, A. y Szatkowski, L. (2014). Characteristics of smokers who have never tried to quit: evidence from the British Opinions and Lifestyle Survey. BMC Public Health, 14, 346. doi:10.1186/1471-2458-14-346.

Siru, R., Hulse, G.K. y Tait, R.J. (2009). Assessing motivation to quit smoking in people with mental illness: a review. Addiction, 104, 719-733. doi:10.1111/j.1360-0443.2009.02545.x.

Tidey, J.W. y Miller, M.E. (2015). Smoking cessation and reduction in people with chronic mental illness. BMJ, 351, h4065. doi:10.1136/bmj.h4065.

Torrent, C., Bonnin, C del M., Martínez-Arán, A., Valle, J., Amann, B.L., González-Pinto, A.,… Vieta, E. (2013). Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. American Journal of Psychiatry, 170, 852-859. doi:10.1176/appi.ajp.2012.12070971.

Vieta, E., Popovic, D., Rosa, A.R., Solé, B., Grande, I., Frey, B.N.,… Kapczinski, F. (2013). The clinical implications of cognitive impairment and allostatic load in bipolar disorder. European Psychiatry, 28, 21-29. doi:10.1016/j.eurpsy.2011.11.007.

Weinberger, A.H., Krishnan-Sarin, S., Mazure, C.M. y McKee, S.A. (2008). Relationship of perceived risks of smoking cessation to symptoms of withdrawal, craving, and depression during short-term smoking abstinence. Addictive Behaviour, 33, 960-963. doi:10.1016/j.addbeh.2008.02.013.

West. R., McNeill, A. y Raw, M. (2000). Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax, 55, 987-999. doi:10.1016/j.eurpsy.2011.11.007.

West, R., Raw, M., McNeill, A., Stead, L., Aveyard, P., Bitton, J.,… Borland, R. (2015). Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction, 110, 1388-1403. doi:10.1111/add.12998.

Wu, B.S., Weinberger, A.H., Mancuso, E., Wing, V.C., Haji-Khamneh, B., Levinson, A.J. y George, T.P. (2012). A Preliminary Feasibility Study of Varenicline for Smoking Cessation in Bipolar Disorder. Journal of Dual Diagnosis, 8, 131-132. doi:10.1080/15504263.2012.671067.

Young, R.C., Biggs, J.T., Ziegler, V.E. y Meyer, D.A. (1978). A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133, 429-435.

Zolnierek, K.B. y Dimatteo, M.R. (2009). Physician communication and patient adherence to treatment: a meta-analysis. Medical Care, 47, 826-834. doi:10.1097/MLR.0b013e31819a5acc.

Archivos adicionales

Publicado

2018-07-13

Número

Sección

Originales